ANTI-TUMOR ANTIBODIES AS CARRIERS OF RADIONUCLEIDES AND CYTOTOXIC DRUGS

被引：0
|
作者：
GHOSE, T [1 ]
TAI, J [1 ]
BLAIR, AH [1 ]
BELITSKY, P [1 ]
AQUINO, J [1 ]
NORVELL, ST [1 ]
机构：
[1] DALHOUSIE UNIV,FAC MED,HALIFAX B3H 4J1,NS,CANADA
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [41] CYTOGENETIC EFFECTS OF ANTI-TUMOR DRUGS IN MAN INVIVO
    STEVENS, DJG
    SCOTT, D
    STURELID, S
    THATCHER, N
    WILKINSON, PM
    STEWART, A
    MUTATION RESEARCH, 1980, 74 (03): : 242 - 242
  • [42] EFFECT OF ANTI-TUMOR DRUGS ON PROTEIN-SYNTHESIS
    CHOWDHURY, K
    NEOGY, RK
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 1980, 18 (02) : 120 - 122
  • [43] Anti-tumor activity of anti-RON antibodies and biomarker of response
    Han, M.
    Whalen, K.
    Gifford, J.
    Boudrow, A.
    Meetze, K.
    Liu, Q.
    Feng, B.
    Winston, W.
    Weiler, S.
    Gyuris, J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 3 - 3
  • [44] Irregularity Indices for Certain Anti-Tumor and Anti-Covid Drugs
    Rauf, Abdul
    Naeem, Muhammad
    Maqbool, Saba
    Siddiqui, Muhammad Kamran
    POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (09) : 6614 - 6627
  • [45] Extracellu ar vesicles as shuttles of tumor biomarkers and anti-tumor drugs
    Zocco, Davide
    Ferruzzi, Pietro
    Cappello, Francesco
    Kuo, Winston Patrick
    Fais, Stefano
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [46] MURINE NATURAL ANTI-TUMOR ANTIBODIES .2. THE CONTRIBUTION OF NATURAL ANTIBODIES TO TUMOR SURVEILLANCE
    CHOW, DA
    WOLOSIN, LB
    GREENBERG, AH
    INTERNATIONAL JOURNAL OF CANCER, 1981, 27 (04) : 459 - 469
  • [47] Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo
    Khazen, Roxana
    Cazaux, Marine
    Lemaitre, Fabrice
    Corre, Beatrice
    Garcia, Zacarias
    Bousso, Philippe
    EMBO JOURNAL, 2021, 40 (11):
  • [48] Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor
    Vande Casteele, Niels
    Abreu, Maria T.
    Flier, Sarah
    Papamichael, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 465 - +
  • [49] Advances in structural design of lipid-based nanoparticle carriers for delivery of macromolecular drugs, phytochemicals and anti-tumor agents
    Angelova, Angelina
    Garamus, Vasil M.
    Angelov, Borislav
    Tian, Zhenfen
    Li, Yawen
    Zou, Aihua
    ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2017, 249 : 331 - 345
  • [50] PHOSPHOLIPID VESICLES AS CARRIERS FOR ANTI TUMOR DRUGS - PHARMACOKINETICS INVIVO
    JULIANO, RL
    BIOPHYSICAL JOURNAL, 1977, 17 (02) : A130 - A130
12345